Redo TAVR Hot Topics – Free July Webinar

June 25th, 2024

Redo TAVR Hot Topics

ViVitro Labs and The Cardiovascular Translational Lab at St. Paul’s bring the latest in translational cardiovascular research in a free, quarterly interactive webinar format. On July 24th @ 10:00am EDT, ViVitro Labs and The Cardiovascular Translational Lab at St. Paul’s present: Redo TAVR Hot Topics.

Redo TAVR Hot Topics features:

– Dr. Gilbert Tang – “Indications, planning, and outcomes”
– Dr. Miho Fukui – “The Redo TAVR App”
– Dr. Stephanie Sellers – “Implications of SVD”

This webinar is a much requested update to our highly rated July 2022 Redo TAVR webinar.

The webinar and audience Q&A will be moderated by Dr. David Meier, CHUV Lausanne, Vaud, Switzerland. The webinar will be recorded and available afterwards to watch anytime. Audience discussion sessions will not be recorded and will only be available to those viewing live.

REGISTER NOW!

Clear your calendar to take part in the interactive format. Attendees rated the April 2024 webinar “9.2/10” in an exit survey.

 

SPEAKERS:

Miho Fukui, MD, PhD

Associate Scientific Director, Imaging Core Lab · Minneapolis Heart Institute Foundation

Dr. Miho Fukui, an established cardiologist and researcher, began her journey in Hyogo, Japan, where she earned both her Medical Degree and PhD. Specializing in echocardiography, she completed her cardiology fellowship in Japan before moving to the U.S in October 2017.

At the University of Pittsburgh, she served as a post-doctorate research scholar, focusing on advanced multi-modality imaging techniques, including Cardiac CT and MRI. Her dedication and expertise led her to the Minneapolis Heart Institute Foundation in September 2018, where she currently serves as an Associate Scientific Director for the Cardiovascular Imaging Research Center and Core Lab.

Dr. Fukui’s passion for multimodality imaging has culminated in over 70 peer-reviewed original investigations and several book chapters. She is a speaker at national and international conferences and active in training workshops.

Gilbert Tang, MD, MSc, MBA, FRCSC, FACC, FSCAI

Surgical Director of the Structural Heart Program | Department of Cardiovascular Surgery· Mount Sinai Health System | Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai

Gilbert Tang is the Surgical Director of the Structural Heart Program at the Mount Sinai Health System and a Professor in the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai. He has performed over 4,000 cases of transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (transcatheter edge-to-edge repair) (TEER with MitraClip), transcatheter tricuspid valve repair (TriClip), and transcatheter mitral and tricuspid valve replacement procedures with excellent outcomes, on par with some of the top programs in the country. The TAVR program recently earned the top 3-star rating in outcomes in the US ACC/STS TVT Registry, one of the few in the country.

Dr. Tang received his bachelor’s degree at Harvard University and MD at the University of Toronto, where he completed his residency in cardiac surgery as the Chief Resident at the Toronto General Hospital. He also completed a Master of Science in tissue engineering at the University of Toronto and an MBA at the Harvard Business School.

Subsequently, Dr. Tang pursued specialized training at Mount Sinai Medical Center in New York focusing on complex mitral valve repair and TAVR, while also underwent advanced training in TAVR at the Leipzig Heart Center in Germany and the University of Pennsylvania. He is a Diplomat and Fellow of the Royal College of Physicians and Surgeons of Canada (FRCSC), Fellow of the American College of Cardiology (FACC), and one of the very few surgeons to be a Fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI).

Stephanie L Sellers MSc PhD

Assistant Professor | Director, Fundamental Research Cardiovascular Imaging, Radiology· UBC Division of Cardiology | St. Paul’s Hospital

Dr. Stephanie Sellers is an assistant professor in the University of British Columbia (UBC) in the Department of Medicine and Division of Cardiology working at the Centre for Heart Lung Innovation at St. Paul’s Hospital. She completed her Master’s at the University of Northern BC (Vascular Physiology), her PhD (Pharmacology & Therapeutics) and Post-Doctoral Fellowship (Radiology) at UBC during which she also trained at the University of Western Australia and Yale University.

Stephanie’s work primarily focuses on determining the mechanisms of heart valve disease and artificial heart valve dysfunction as well as advancing emerging imaging techniques for cardiovascular disease using in-vivo and ex-vivo models.

 

Moderator

Dr David Meier
Interventional cardiologist
Lausanne University Hospital

Dr. David Meier is an interventional cardiologist at Lausanne University Hospital in Switzerland. He earned his medical degree from the University of Lausanne, followed by specialized training in internal medicine and cardiology. He then completed a fellowship in interventional cardiology in Vancouver, Canada. Alongside his clinical duties, Dr. Meier maintains an active research collaboration with the cardiovascular translational lab in Vancouver.

 

About ViVitro Labs

Hundreds of organizations in over 39 countries for 35 years have trusted ViVitro expertise, reliability, and quality in testing heart valves, LVAD, interventional devices, stent, and stent-graft. ViVitro Laboratory Services have two ISO/IEC 17025 accredited laboratories (see our ISO 17925 scope of accreditation for Marseille, France and Victoria, Canada). ViVitro Labs products are manufactured by StarFish Medical in Victoria, Canada. https://vivitrolabs.com/

    Join over 5000 cardiovascular device professionals who receive our testing and engineering insights and tips every month.